BioSpace News Archive

Business

FSD Pharma Announces Research Agreement with Solarvest to Develop Algae-based, Pharma-grade Cannabinoids

Process Could Significantly Reduce Cannabinoid Production Time

May 7, 2019
·
8 min read
Drug Development

Repair Biotechnologies Raises $2.15M Seed Round to Develop Drugs for Age-Related Diseases

Repair Biotechnologies, Inc. announced $2.15 million in seed venture funding, to accelerate the preclinical development of its pipeline of drugs targeting thymus regeneration, cancer, and atherosclerosis.

May 7, 2019
·
2 min read
Business

Henry Schein Reports Record First Quarter 2019 Financial Results from Continuing Operations

Q1 GAAP net income per diluted share from continuing operations of $0.78 versus prior-year GAAP net income per diluted share from continuing operations of $0.72

May 7, 2019
·
23 min read
Business

Eagle Pharmaceuticals, Inc. Reports First Quarter 2019 Results

Q1 2019 net income of $0.64 per basic and $0.62 per diluted share and adjusted non-GAAP net income of $1.05 per basic and $1.01 per diluted share

May 7, 2019
·
17 min read
Deals

Avanos Medical, Inc. Announces First Quarter 2019 Results

Avanos Medical, Inc. reported first quarter 2019 results.

May 7, 2019
·
8 min read
Business

DataLink Software Partners with the Florida Association of Health Plans as an Associate Member

Premier value-based healthcare technology company joins health plan association to assist in empowering healthcare in the state of Florida

May 7, 2019
·
1 min read
Deals

Evogene Financial Results for the First Quarter of 2019

Evogene Ltd announced that it will release its financial results for the first quarter of 2019 on Tuesday, May 28, 2019.

May 7, 2019
·
3 min read
Deals

Intec Pharma Reports First Quarter 2019 Financial Results and Corporate Update

Intec Pharma Ltd. announces financial results for the three months ended March 31, 2019 and provides a corporate update.

May 7, 2019
·
14 min read
Drug Development

Protagonist Therapeutics to Present Preclinical Data on PN-943 at Digestive Disease Week Conference 2019

Oral plenary presentation to detail properties of oral, gut-restricted alpha-4-beta-7 integrin antagonist candidate PN-943

May 7, 2019
·
4 min read
BioForest

TransformativeMed Closes $5.8 Series A to Redefine How Clinicians Use the EHR to Communicate and Collaborate

TransformativeMed announced that it has closed a $5.8M Series A financing round led by the Alliance of Angels.

May 7, 2019
·
3 min read